AI-powered search
AI-powered search

2024 Virtual Grand Rounds

2024 Virtual Grand Rounds Session 8: May 15, 2024 - Are Robots Taking Over? Augmented Intelligence in Dermatology & Practice Survival Strategies

About

Fall Clinical Virtual Grand Rounds consist of regularly scheduled CME sessions on a variety of dermatological diseases, delivered by the top experts in dermatology. Please join us for this week's session:

Wednesday, May 15, 2024

8 PM ET / 5 PM PT

Are Robots Taking Over? Augmented Intelligence in Dermatology

Practice Survival Strategies

Availability

In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:

Release Date:

May 16, 2024

Expiration Date:

May 16, 2025

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Identify the application of AI for diagnosis

  • Review generative AI in dermatology

  • Outline the current reimbursement landscape

  • Review ways to use the entire physician fee schedule

Intended Audience

This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.

Faculty
April
April Armstrong, MD, MPH

Chief, Division of Dermatology
David Geffen School of Medicine at UCLA
Los Angeles, CA

Mark
Mark Kaufmann, MD

Chief Medical Officer, Advanced Dermatology and Cosmetic Surgery
Clinical Professor, Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY

Lisa
Lisa Swanson, MD

Pediatric Dermatologist 
Ada West Dermatology 
Boise, ID

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

Disclosures are as follows:

April W. Armstrong, MD, MPH

Grant/Research Support: BMS, Leo, UCB, Lilly, Dermavant, Dermira, Pfizer, AbbVie, ASLAN, BI, EPI, Incyte, Janssen 

Consultant: Lilly, Novartis, Ortho, SUN, Dermavant, Dermira, Sanofi Regeneron, Pfizer, Parexel 

Mark D. Kaufmann, MD

Consultant: Apogee Therapeutics, Avita Medical, Biofrontera, Dermagnostix, Dermtech,Incyte, Novan, Novartis, Rise Healthcare, Rivera Consulting, UCB, Verrica

Ownership Interest (privately held): Modernizing Medicine, Molesafe

Lisa A. Swanson, MD

Consultant: Janssen, Lilly, Ortho Dermatologics, Sanofi-Regeneron, Pfizer, LEO, Novan, Arcutis

Speakers’ Bureau or Honoraria: Ortho Dermatologics, Pfizer, Amgen, Sanofi-Regeneron, Almirall, Janssen, Lilly, Novartis, Abbvie, Incyte 

The Institute discloses that all relevant conflicts have been satisfactorily mitigated.


Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved